Company Description
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States.
The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.
Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals.
The company is headquartered in Dallas, Texas.
| Country | United States |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 78 |
| CEO | Peter Carlson |
Contact Details
Address: 2515 McKinney Avenue, Suite 1000 Dallas, Texas 75201 United States | |
| Phone | 972 499 4934 |
| Website | spectral-ai.com |
Stock Details
| Ticker Symbol | MDAI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001833498 |
| CUSIP Number | 84757T105 |
| ISIN Number | US84757T1051 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Erich L. Spangenberg | Chief Executive Officer of Health care and Director |
| Wensheng Fan | Co-Founder, Chief Innovation Strategist and Senior Advisor to the Chief Executive Officer |
| Vincent Stanley Capone | Chief Financial Officer, General Counsel and Corporate Secretary |
| Christine Marks | Vice President of Marketing and Commercialization |
| Dr. John Michael DiMaio M.D. | Founder and Chairman |
| Stan Micek | Interim Chief Operating Officer |
| Prof. Paul Chadwick | Executive Vice President of UK and EMEA |
| Jeremiah A. Sparks MBA | Chief Commercialization Officer |
| David Bronson | Financial Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 12, 2024 | 424B5 | Filing |
| Dec 11, 2024 | 8-K | Current Report |
| Dec 9, 2024 | 424B5 | Filing |
| Dec 4, 2024 | 424B3 | Prospectus |
| Dec 2, 2024 | EFFECT | Notice of Effectiveness |
| Nov 21, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Nov 18, 2024 | 424B5 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 6, 2024 | 10-Q | Quarterly Report |
| Oct 31, 2024 | EFFECT | Notice of Effectiveness |